These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 19393823)
1. The potential role of nitric oxide in cardiovascular safety when treating patients with osteoarthritis and hypertension: a moderated panel discussion. White WB; Pepine CJ; Weber MA Am J Med; 2009 May; 122(5 Suppl):S23-5. PubMed ID: 19393823 [No Abstract] [Full Text] [Related]
2. The potential role of nitric oxide in cardiovascular safety when treating osteoarthritis in patients with hypertension. Introduction. White WB Am J Med; 2009 May; 122(5 Suppl):S1-2. PubMed ID: 19393820 [No Abstract] [Full Text] [Related]
3. Treatment of patients with hypertension and arthritis pain: new concepts. Weber MA Am J Med; 2009 May; 122(5 Suppl):S16-22. PubMed ID: 19393822 [TBL] [Abstract][Full Text] [Related]
4. Defining the problem of treating the patient with hypertension and arthritis pain. White WB Am J Med; 2009 May; 122(5 Suppl):S3-9. PubMed ID: 19393824 [TBL] [Abstract][Full Text] [Related]
6. Development of novel agents based on nitric oxide for the control of colon cancer. Kozoni V; Rosenberg T; Rigas B Acta Pharmacol Sin; 2007 Sep; 28(9):1429-33. PubMed ID: 17723176 [TBL] [Abstract][Full Text] [Related]
7. Effects of the cyclooxygenase inhibiting nitric oxide donator naproxcinod versus naproxen on systemic blood pressure in patients with osteoarthritis. White WB; Schnitzer TJ; Fleming R; Duquesroix B; Beekman M Am J Cardiol; 2009 Sep; 104(6):840-5. PubMed ID: 19733721 [TBL] [Abstract][Full Text] [Related]
9. New nitric oxide-donating drugs for the treatment of airway diseases. Lagente V; Advenier C Curr Opin Investig Drugs; 2004 May; 5(5):537-41. PubMed ID: 15202728 [TBL] [Abstract][Full Text] [Related]
10. How do glucocorticoids cause hypertension: role of nitric oxide deficiency, oxidative stress, and eicosanoids. Ong SL; Whitworth JA Endocrinol Metab Clin North Am; 2011 Jun; 40(2):393-407, ix. PubMed ID: 21565674 [TBL] [Abstract][Full Text] [Related]
11. Decreased threshold for the nitric oxide donor glyceryl trinitrate in cortisol-induced hypertension in humans. Kelly JJ; Tam SH; Williamson PM; Whitworth JA Clin Exp Pharmacol Physiol; 2007 Dec; 34(12):1317-8. PubMed ID: 17973874 [TBL] [Abstract][Full Text] [Related]
12. Nitric oxide and cardiovascular effects: new insights in the role of nitric oxide for the management of osteoarthritis. Mackenzie IS; Rutherford D; MacDonald TM Arthritis Res Ther; 2008; 10 Suppl 2(Suppl 2):S3. PubMed ID: 19007428 [TBL] [Abstract][Full Text] [Related]
13. New Nitric Oxide Donors With Therapeutic Potential. Buca BR; Mititelu-Tarţau L; Lupuşoru RV; Popa GE; Rezuş C; Lupuşoru CE Rev Med Chir Soc Med Nat Iasi; 2016; 120(4):942-6. PubMed ID: 30141891 [TBL] [Abstract][Full Text] [Related]
14. Nitric oxide donors: novel cancer therapeutics (review). Huerta S; Chilka S; Bonavida B Int J Oncol; 2008 Nov; 33(5):909-27. PubMed ID: 18949354 [TBL] [Abstract][Full Text] [Related]
15. Osteoarthritis and chondroprotection. Mevorach D; Menkes CJ Isr J Med Sci; 1994 Dec; 30(12):928-31. PubMed ID: 8002283 [No Abstract] [Full Text] [Related]